Intravenous delivery of adeno-associated viral vector serotype 9 mediates effective gene expression in ischemic stroke lesion and brain angiogenic foci

Stroke

Volumn 44, Issue 1, 2013, Pages 252-254

  Shen, Fanxia ^a   Kuo, Robert ^a   Milon Camus, Marine ^a   Han, Zhenying ^a   Jiang, Lidan ^a   Young, William L ^a   Su, Hua ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

adeno associated viral vector serotype 9; angiogenesis; brain; intravenous delivery; mouse; peri infarct region

Indexed keywords

BETA GALACTOSIDASE; PARVOVIRUS VECTOR; RECOMBINANT VASCULOTROPIN;

ADENO ASSOCIATED VIRUS; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASAL GANGLION; BRAIN ANGIOGENIC FOCI; BRAIN ISCHEMIA; CONTROLLED STUDY; CYTOMEGALOVIRUS; GENE EXPRESSION; HYPOXIA; JUGULAR VEIN; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRAL GENE DELIVERY SYSTEM; VIRUS CAPSID;

ANIMALS; BRAIN; BRAIN ISCHEMIA; DEPENDOVIRUS; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; INJECTIONS, INTRAVENOUS; MALE; MICE; NEOVASCULARIZATION, PATHOLOGIC; SEROTYPING; STROKE;

EID: 84872077107     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.112.662965     Document Type: Article

References (10)

1. McCown TJ, Xiao X, Li J, Breese GR, Samulski RJ. Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res. 1996;713:99-107.
2. Shen F, Walker EJ, Jiang L, Degos V, Li J, Sun B, et al. Coexpression of angiopoietin-1 with VEGF increases the structural integrity of the blood-brain barrier and reduces atrophy volume. J Cereb Blood Flow Metab. 2011;31:2343-2351.
3. Manfredsson FP, Rising AC, Mandel RJ. AAV9: a potential blood-brain barrier buster. Mol Ther. 2009;17:403-405.
4. Foust KD, Nurre E, Montgomery CL, Hernandez A, Chan CM, Kaspar BK.Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat Biotechnol. 2009;27:59-65.
5. Duque S, Joussemet B, Riviere C, Marais T, Dubreil L, Douar AM, et al.Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons. Mol Ther. 2009;17:1187-1196.
6. Shen F, Su H, Liu W, Kan YW, Young WL, Yang GY. Recombinant adeno-associated viral vector encoding human VEGF165 induces neomicrovessel formation in the adult mouse brain. Front Biosci. 2006;11:3190-3198.
7. Su H, Arakawa-Hoyt J, Kan YW. Adeno-associated viral vector-mediated hypoxia response element-regulated gene expression in mouse ischemic heart model. Proc Natl Acad Sci USA. 2002;99:9480-9485.
8. Gray SJ, Matagne V, Bachaboina L, Yadav S, Ojeda SR, Samulski RJ. Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates. Mol Ther. 2011;19:1058-1069.
9. Chen LP, Xu HM, Zhao W, Zhang SH, Zhu ZY, Zhang Q, et al. [Photomacrography of brain surface for evaluating blood-brain barrier disruption within 24 h after focal cerebral ischemia in mice]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2005;34:523-528.
10. Valable S, Montaner J, Bellail A, Berezowski V, Brillault J, Cecchelli R, et al. VEGF-induced BBB permeability is associated with an MMP-9 activity increase in cerebral ischemia: both effects decreased by Ang-1. J Cereb Blood Flow Metab. 2005;25:1491-1504.